The degree of intratumor mutational heterogeneity varies by primary tumor sub-site

Levi G. Ledgerwood, Dhruv Kumar, Agda Karina Eterovic, Jo Wick, Ken Chen, Hao Zhao, Loubna Tazi, Pradip Manna, Spencer Kerley, Radhika Joshi, Lin Wang, Simion I. Chiosea, James David Garnett, Terance Ted Tsue, Jeremy Chien, Gordon Mills, Jennifer Rubin Grandis, Sufi Mary Thomas

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

In an era where mutational profiles inform treatment options, it is critical to know the extent to which tumor biopsies represent the molecular profile of the primary and metastatic tumor. Head and neck squamous cell carcinoma (HNSCC) arise primarily in the mucosal lining of oral cavity and oropharynx. Despite aggressive therapy the 5-year survival rate is at 50%. The primary objective of this study is to characterize the degree of intratumor mutational heterogeneity in HNSCC. We used multi-region sequencing of paired primary and metastatic tumor DNA of 24 spatially distinct samples from seven patients with HNSCC of larynx, floor of the mouth (FOM) or oral tongue. Full length, in-depth sequencing of 202 genes implicated in cancer was carried out. Larynx and FOM tumors had more than 69.2% unique SNVs between the paired primary and metastatic lesions. In contrast, the oral tongue HNSCC had only 33.3% unique SNVs across multiple sites. In addition, HNSCC of the oral tongue had fewer mutations than larynx and FOM tumors. These findings were validated on the Affymetrix whole genome 6.0 array platform and were consistent with data from The Cancer Genome Atlas (TCGA). This is the first report demonstrating differences in mutational heterogeneity varying by subsite in HNSCC. The heterogeneity within laryngeal tumor specimens may lead to an underestimation of the genetic abnormalities within tumors and may foster resistance to standard treatment protocols. These findings are relevant to investigators and clinicians developing personalized cancer treatments based on identification of specific mutations in tumor biopsies.

Original languageEnglish (US)
Pages (from-to)27185-27198
Number of pages14
JournalOncotarget
Volume7
Issue number19
DOIs
StatePublished - May 10 2016
Externally publishedYes

Fingerprint

Mouth Floor
Neoplasms
Larynx
Tongue
Genome
Biopsy
Mutation
Oropharynx
Atlases
Clinical Protocols
Mouth
Carcinoma, squamous cell of head and neck
Therapeutics
Survival Rate
Research Personnel
DNA
Genes

Keywords

  • Deep sequencing
  • HNSCC
  • HPV
  • Intratumor heterogeneity
  • Mutation

ASJC Scopus subject areas

  • Oncology

Cite this

Ledgerwood, L. G., Kumar, D., Eterovic, A. K., Wick, J., Chen, K., Zhao, H., ... Thomas, S. M. (2016). The degree of intratumor mutational heterogeneity varies by primary tumor sub-site. Oncotarget, 7(19), 27185-27198. https://doi.org/10.18632/oncotarget.8448

The degree of intratumor mutational heterogeneity varies by primary tumor sub-site. / Ledgerwood, Levi G.; Kumar, Dhruv; Eterovic, Agda Karina; Wick, Jo; Chen, Ken; Zhao, Hao; Tazi, Loubna; Manna, Pradip; Kerley, Spencer; Joshi, Radhika; Wang, Lin; Chiosea, Simion I.; Garnett, James David; Tsue, Terance Ted; Chien, Jeremy; Mills, Gordon; Grandis, Jennifer Rubin; Thomas, Sufi Mary.

In: Oncotarget, Vol. 7, No. 19, 10.05.2016, p. 27185-27198.

Research output: Contribution to journalArticle

Ledgerwood, LG, Kumar, D, Eterovic, AK, Wick, J, Chen, K, Zhao, H, Tazi, L, Manna, P, Kerley, S, Joshi, R, Wang, L, Chiosea, SI, Garnett, JD, Tsue, TT, Chien, J, Mills, G, Grandis, JR & Thomas, SM 2016, 'The degree of intratumor mutational heterogeneity varies by primary tumor sub-site', Oncotarget, vol. 7, no. 19, pp. 27185-27198. https://doi.org/10.18632/oncotarget.8448
Ledgerwood LG, Kumar D, Eterovic AK, Wick J, Chen K, Zhao H et al. The degree of intratumor mutational heterogeneity varies by primary tumor sub-site. Oncotarget. 2016 May 10;7(19):27185-27198. https://doi.org/10.18632/oncotarget.8448
Ledgerwood, Levi G. ; Kumar, Dhruv ; Eterovic, Agda Karina ; Wick, Jo ; Chen, Ken ; Zhao, Hao ; Tazi, Loubna ; Manna, Pradip ; Kerley, Spencer ; Joshi, Radhika ; Wang, Lin ; Chiosea, Simion I. ; Garnett, James David ; Tsue, Terance Ted ; Chien, Jeremy ; Mills, Gordon ; Grandis, Jennifer Rubin ; Thomas, Sufi Mary. / The degree of intratumor mutational heterogeneity varies by primary tumor sub-site. In: Oncotarget. 2016 ; Vol. 7, No. 19. pp. 27185-27198.
@article{6a4a9836277b421086dc56e771f8495e,
title = "The degree of intratumor mutational heterogeneity varies by primary tumor sub-site",
abstract = "In an era where mutational profiles inform treatment options, it is critical to know the extent to which tumor biopsies represent the molecular profile of the primary and metastatic tumor. Head and neck squamous cell carcinoma (HNSCC) arise primarily in the mucosal lining of oral cavity and oropharynx. Despite aggressive therapy the 5-year survival rate is at 50{\%}. The primary objective of this study is to characterize the degree of intratumor mutational heterogeneity in HNSCC. We used multi-region sequencing of paired primary and metastatic tumor DNA of 24 spatially distinct samples from seven patients with HNSCC of larynx, floor of the mouth (FOM) or oral tongue. Full length, in-depth sequencing of 202 genes implicated in cancer was carried out. Larynx and FOM tumors had more than 69.2{\%} unique SNVs between the paired primary and metastatic lesions. In contrast, the oral tongue HNSCC had only 33.3{\%} unique SNVs across multiple sites. In addition, HNSCC of the oral tongue had fewer mutations than larynx and FOM tumors. These findings were validated on the Affymetrix whole genome 6.0 array platform and were consistent with data from The Cancer Genome Atlas (TCGA). This is the first report demonstrating differences in mutational heterogeneity varying by subsite in HNSCC. The heterogeneity within laryngeal tumor specimens may lead to an underestimation of the genetic abnormalities within tumors and may foster resistance to standard treatment protocols. These findings are relevant to investigators and clinicians developing personalized cancer treatments based on identification of specific mutations in tumor biopsies.",
keywords = "Deep sequencing, HNSCC, HPV, Intratumor heterogeneity, Mutation",
author = "Ledgerwood, {Levi G.} and Dhruv Kumar and Eterovic, {Agda Karina} and Jo Wick and Ken Chen and Hao Zhao and Loubna Tazi and Pradip Manna and Spencer Kerley and Radhika Joshi and Lin Wang and Chiosea, {Simion I.} and Garnett, {James David} and Tsue, {Terance Ted} and Jeremy Chien and Gordon Mills and Grandis, {Jennifer Rubin} and Thomas, {Sufi Mary}",
year = "2016",
month = "5",
day = "10",
doi = "10.18632/oncotarget.8448",
language = "English (US)",
volume = "7",
pages = "27185--27198",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "19",

}

TY - JOUR

T1 - The degree of intratumor mutational heterogeneity varies by primary tumor sub-site

AU - Ledgerwood, Levi G.

AU - Kumar, Dhruv

AU - Eterovic, Agda Karina

AU - Wick, Jo

AU - Chen, Ken

AU - Zhao, Hao

AU - Tazi, Loubna

AU - Manna, Pradip

AU - Kerley, Spencer

AU - Joshi, Radhika

AU - Wang, Lin

AU - Chiosea, Simion I.

AU - Garnett, James David

AU - Tsue, Terance Ted

AU - Chien, Jeremy

AU - Mills, Gordon

AU - Grandis, Jennifer Rubin

AU - Thomas, Sufi Mary

PY - 2016/5/10

Y1 - 2016/5/10

N2 - In an era where mutational profiles inform treatment options, it is critical to know the extent to which tumor biopsies represent the molecular profile of the primary and metastatic tumor. Head and neck squamous cell carcinoma (HNSCC) arise primarily in the mucosal lining of oral cavity and oropharynx. Despite aggressive therapy the 5-year survival rate is at 50%. The primary objective of this study is to characterize the degree of intratumor mutational heterogeneity in HNSCC. We used multi-region sequencing of paired primary and metastatic tumor DNA of 24 spatially distinct samples from seven patients with HNSCC of larynx, floor of the mouth (FOM) or oral tongue. Full length, in-depth sequencing of 202 genes implicated in cancer was carried out. Larynx and FOM tumors had more than 69.2% unique SNVs between the paired primary and metastatic lesions. In contrast, the oral tongue HNSCC had only 33.3% unique SNVs across multiple sites. In addition, HNSCC of the oral tongue had fewer mutations than larynx and FOM tumors. These findings were validated on the Affymetrix whole genome 6.0 array platform and were consistent with data from The Cancer Genome Atlas (TCGA). This is the first report demonstrating differences in mutational heterogeneity varying by subsite in HNSCC. The heterogeneity within laryngeal tumor specimens may lead to an underestimation of the genetic abnormalities within tumors and may foster resistance to standard treatment protocols. These findings are relevant to investigators and clinicians developing personalized cancer treatments based on identification of specific mutations in tumor biopsies.

AB - In an era where mutational profiles inform treatment options, it is critical to know the extent to which tumor biopsies represent the molecular profile of the primary and metastatic tumor. Head and neck squamous cell carcinoma (HNSCC) arise primarily in the mucosal lining of oral cavity and oropharynx. Despite aggressive therapy the 5-year survival rate is at 50%. The primary objective of this study is to characterize the degree of intratumor mutational heterogeneity in HNSCC. We used multi-region sequencing of paired primary and metastatic tumor DNA of 24 spatially distinct samples from seven patients with HNSCC of larynx, floor of the mouth (FOM) or oral tongue. Full length, in-depth sequencing of 202 genes implicated in cancer was carried out. Larynx and FOM tumors had more than 69.2% unique SNVs between the paired primary and metastatic lesions. In contrast, the oral tongue HNSCC had only 33.3% unique SNVs across multiple sites. In addition, HNSCC of the oral tongue had fewer mutations than larynx and FOM tumors. These findings were validated on the Affymetrix whole genome 6.0 array platform and were consistent with data from The Cancer Genome Atlas (TCGA). This is the first report demonstrating differences in mutational heterogeneity varying by subsite in HNSCC. The heterogeneity within laryngeal tumor specimens may lead to an underestimation of the genetic abnormalities within tumors and may foster resistance to standard treatment protocols. These findings are relevant to investigators and clinicians developing personalized cancer treatments based on identification of specific mutations in tumor biopsies.

KW - Deep sequencing

KW - HNSCC

KW - HPV

KW - Intratumor heterogeneity

KW - Mutation

UR - http://www.scopus.com/inward/record.url?scp=84968750705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84968750705&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.8448

DO - 10.18632/oncotarget.8448

M3 - Article

VL - 7

SP - 27185

EP - 27198

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 19

ER -